E. Bribes

发表

SSR125329A, a high affinity σ receptor ligand with potent anti-inflammatory properties

S. Galiègue, P. Casellas, Corinne J Thomas, 2002 .

Early Quantitative Evaluation of a Tumor Vasculature Disruptive Agent AVE8062 Using Dynamic Contrast-Enhanced Ultrasonography

P. Vrignaud, S. Koscielny, N. Lassau, 2008, Investigative radiology.

The CB1 receptor antagonist rimonabant reverses the diet‐induced obesity phenotype through the regulation of lipolysis and energy balance

P. Soubrié, S. Galiègue, P. Casellas, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Survival and regeneration of neurons of the supraoptic nucleus following surgical transection of neurohypophysial axons depend on the existence of collateral projections of these neurons to the dorsolateral hypothalamus

G. Alonso, E. Bribes, N. Chauvet, 1996, Brain Research.

The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: implications for multiple sclerosis treatment.

P. Casellas, J. Maffrand, B. Bourrie, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Identification and pharmacological characterization of SRBP-2: a novel SR31747A-binding protein.

S. Galiègue, P. Casellas, A. Kramar, 2003, Cancer research.

Cloning and Characterization of PRAX-1

S. Galiègue, P. Casellas, G. Le Fur, 1999, The Journal of Biological Chemistry.

Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors

P. Casellas, A. Kramar, S. Gourgou, 2000, British Journal of Cancer.

Involvement of the peripheral benzodiazepine receptor in the development of rheumatoid arthritis in Mrl/lpr mice.

S. Galiègue, P. Casellas, H. Vidal, 2002, European journal of pharmacology.

Ligands of the peripheral benzodiazepine receptor have therapeutic effects in pneumopathies in vivo.

P. Casellas, E. Bribes, B. Bourrié, 2003, Immunology letters.

Involvement of the peripheral benzodiazepine receptor in the development of cutaneous pathology in Mrl/Lpr mice.

S. Galiègue, P. Casellas, E. Bribes, 2003, Immunology letters.

Peripheral benzodiazepine receptor mapping in rat kidney. Effects of angiotensin II-induced hypertension.

P. Casellas, D. Casellas, D. Dussossoy, 2002, Journal of the American Society of Nephrology : JASN.

Sigma receptor ligands: applications in inflammation and oncology.

P. Casellas, J. Derocq, H. Vidal, 2004, Current opinion in investigational drugs.

The HDAC inhibitor SAHA does not rescue CFTR membrane expression in Cystic Fibrosis.

M. Claustres, I. Vachier, N. Molinari, 2017, The international journal of biochemistry & cell biology.

Immunohistochemical Assessment of the Peripheral Benzodiazepine Receptor in Human Tissues

S. Galiègue, P. Casellas, E. Bribes, 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

SSR125329A, a high affinity sigma receptor ligand with potent anti-inflammatory properties.

S. Galiègue, P. Casellas, Corinne J Thomas, 2002, European journal of pharmacology.